Cargando…
Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
OBJECTIVES: The role of maximum standard uptake value (SUVmax) at baseline and after induction chemotherapy (CT) on positron emission tomography (PET) as an imaging biomarker has not been well established in oesophageal squamous cell carcinoma (SCC). In this retrospective analysis, we investigated t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702001/ https://www.ncbi.nlm.nih.gov/pubmed/26657654 http://dx.doi.org/10.1038/bjc.2015.416 |
_version_ | 1782408571106885632 |
---|---|
author | Chhabra, Arpit Ong, Leonard T Kuk, Deborah Ku, Geoffrey Ilson, David Janjigian, Yelena Y Wu, Abraham Schöder, Heiko Goodman, Karyn A |
author_facet | Chhabra, Arpit Ong, Leonard T Kuk, Deborah Ku, Geoffrey Ilson, David Janjigian, Yelena Y Wu, Abraham Schöder, Heiko Goodman, Karyn A |
author_sort | Chhabra, Arpit |
collection | PubMed |
description | OBJECTIVES: The role of maximum standard uptake value (SUVmax) at baseline and after induction chemotherapy (CT) on positron emission tomography (PET) as an imaging biomarker has not been well established in oesophageal squamous cell carcinoma (SCC). In this retrospective analysis, we investigated the prognostic significance of various PET metrics in oesophageal SCC patients treated with induction chemotherapy followed by concurrent chemoradiotherapy (CRT). METHODS: A total of 57 patients were treated with CRT; 52 patients received induction chemotherapy and 10 patients underwent surgery following CRT. Scans were independently analysed by a nuclear medicine physician blinded to patient outcome. Using region of interest analysis, SUVmax and metabolic tumour volume (MTV) were calculated for the index lesion and lymph node metastases in each patient. Kaplan–Meier analysis was used to evaluate overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS). Cox proportional hazards regression was used to assess correlation between outcomes and PET metrics. RESULTS: Median follow-up for those who are alive was 4.4 years, with a median survival for all patients of 2.9 years. The 3-year OS, DFS, DMFS and LRFS rates were 47, 40, 44 and 36%, respectively. Using a pre-established cutoff of a 35% decrease in SUVmax from baseline to post-induction PET, 3-year OS for responders (⩾35% decrease from baseline) was 64%, whereas non-responders (<35% decrease from baseline) had a 3-year OS of 15% (P=0.004). CONCLUSIONS: The pre-specified 35% decrease in SUVmax after induction chemotherapy was prognostic for OS. Baseline and post-induction PET metrics provide prognostic information for oesophageal SCC. |
format | Online Article Text |
id | pubmed-4702001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47020012016-12-22 Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma Chhabra, Arpit Ong, Leonard T Kuk, Deborah Ku, Geoffrey Ilson, David Janjigian, Yelena Y Wu, Abraham Schöder, Heiko Goodman, Karyn A Br J Cancer Clinical Study OBJECTIVES: The role of maximum standard uptake value (SUVmax) at baseline and after induction chemotherapy (CT) on positron emission tomography (PET) as an imaging biomarker has not been well established in oesophageal squamous cell carcinoma (SCC). In this retrospective analysis, we investigated the prognostic significance of various PET metrics in oesophageal SCC patients treated with induction chemotherapy followed by concurrent chemoradiotherapy (CRT). METHODS: A total of 57 patients were treated with CRT; 52 patients received induction chemotherapy and 10 patients underwent surgery following CRT. Scans were independently analysed by a nuclear medicine physician blinded to patient outcome. Using region of interest analysis, SUVmax and metabolic tumour volume (MTV) were calculated for the index lesion and lymph node metastases in each patient. Kaplan–Meier analysis was used to evaluate overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS) and distant metastasis-free survival (DMFS). Cox proportional hazards regression was used to assess correlation between outcomes and PET metrics. RESULTS: Median follow-up for those who are alive was 4.4 years, with a median survival for all patients of 2.9 years. The 3-year OS, DFS, DMFS and LRFS rates were 47, 40, 44 and 36%, respectively. Using a pre-established cutoff of a 35% decrease in SUVmax from baseline to post-induction PET, 3-year OS for responders (⩾35% decrease from baseline) was 64%, whereas non-responders (<35% decrease from baseline) had a 3-year OS of 15% (P=0.004). CONCLUSIONS: The pre-specified 35% decrease in SUVmax after induction chemotherapy was prognostic for OS. Baseline and post-induction PET metrics provide prognostic information for oesophageal SCC. Nature Publishing Group 2015-12-22 2015-12-10 /pmc/articles/PMC4702001/ /pubmed/26657654 http://dx.doi.org/10.1038/bjc.2015.416 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Clinical Study Chhabra, Arpit Ong, Leonard T Kuk, Deborah Ku, Geoffrey Ilson, David Janjigian, Yelena Y Wu, Abraham Schöder, Heiko Goodman, Karyn A Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title | Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title_full | Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title_fullStr | Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title_full_unstemmed | Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title_short | Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
title_sort | prognostic significance of pet assessment of metabolic response to therapy in oesophageal squamous cell carcinoma |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702001/ https://www.ncbi.nlm.nih.gov/pubmed/26657654 http://dx.doi.org/10.1038/bjc.2015.416 |
work_keys_str_mv | AT chhabraarpit prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT ongleonardt prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT kukdeborah prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT kugeoffrey prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT ilsondavid prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT janjigianyelenay prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT wuabraham prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT schoderheiko prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma AT goodmankaryna prognosticsignificanceofpetassessmentofmetabolicresponsetotherapyinoesophagealsquamouscellcarcinoma |